ClinicalTrials.gov
public full text
Public Domain
Delivra-Celecoxib 8% Cream and Osteoarthritis
This is an observation of the current use of a transdermal preparation of Celecoxib 8% which is being used in the treatment of patients with primary OA of the knees. Subjects will be followed for 12 weeks.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Effect Of Celecoxib On Hip Osteoarthritis (OA) Progression#1115317
- Perioperative Pain Control With Celecoxib (Celebrex) in Total Knee Arthroplasty#878266
- Leeches for the Treatment of Knee Osteoarthritis#893318
- Use of Etoricoxib Compared to Diclofenac in the Perioperative Treatment of Patients After Total Hip Arthroplasty#876896
- Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3003#1075112
Record · ID 887676
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive